Science and Research

Study to Evaluate the Pharmacokinetics and Pharmacodynamics of AZD4604 Given Via the Turbuhaler® Device in Adults With Mild Asthma.

The study will investigate the Pharmacokinetic (PK), Pharmacodynamic (PD), the safety and tolerability of AZD4604, as well as to examine the effect of Fractional exhaled Nitric Oxide (FeNO) following the administration of the multiple doses of AZD4604 via Turbuhaler device.

Study details
Study-ID: NCT06732882, 2024-516474-30-00
DZL Disease Area: AA
Study Type: Interventional
DZL Role: DZL recruiting center
Funding: Externally - industry
DZL Participating Sites: BREATH
Start Date: 27.02.2025
Completion Date: 17.09.2025
Status: Recruiting
Link to Study


chevron-down